This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Toxicology Excellence for Risk Assessment | |
|---|---|
| Name | Toxicology Excellence for Risk Assessment |
| Abbreviation | TERA |
| Formation | 1995 |
| Type | Nonprofit organization |
| Purpose | Human health risk assessment |
| Headquarters | Cincinnati, Ohio |
| Region served | United States, International |
| Leader title | Director |
Toxicology Excellence for Risk Assessment is an independent nonprofit organization founded in 1995 to provide scientific analyses of chemical risks and toxicological data for regulatory and industrial stakeholders. The organization is known for producing risk assessment reports, participating in advisory panels, and developing tools used by agencies, industry groups, and academic institutions. It collaborates with national laboratories, regulatory bodies, and professional societies to inform decision-making on chemical safety.
TERA was established in the mid-1990s amid debates over chemical regulation following events such as the Toxic Substances Control Act amendments and the implementation of the Food Quality Protection Act. Early interactions involved collaborations with the Environmental Protection Agency, the National Institute for Occupational Safety and Health, and the Agency for Toxic Substances and Disease Registry. Founders and early staff engaged with stakeholders from the American Chemistry Council, the Occupational Safety and Health Administration, and the International Agency for Research on Cancer. Over time, TERA worked alongside institutions such as the Centers for Disease Control and Prevention, United States Geological Survey, and academic centers like Johns Hopkins University and University of Cincinnati.
TERA’s stated mission aligns with principles championed by organizations like the National Academy of Sciences and the World Health Organization for transparent risk characterization. Objectives include producing human health risk assessments, developing toxicological review methodologies, and supporting evidence synthesis similar to guidance from the Institute of Medicine and the National Research Council. It aims to serve regulatory clients such as the Food and Drug Administration, the Department of Defense, and the European Chemicals Agency, while engaging with professional groups including the Society of Toxicology and the International Society of Regulatory Toxicology and Pharmacology.
TERA has an organizational model comparable to nonprofit research centers such as the Lincoln Laboratory and policy-focused institutes like the Brookings Institution in that it combines scientific staff, advisory boards, and external reviewers. Funding sources have included fee-for-service contracts from industrial clients including multinational corporations represented by the International Council on Mining and Metals and philanthropic grants akin to those from the Robert Wood Johnson Foundation. It has received project support from governmental grants involving the National Institutes of Health and cooperative agreements with the Agency for Toxic Substances and Disease Registry. Advisory committees have included independent experts with affiliations to institutions such as Harvard University, Yale University, Stanford University, and the University of California, Berkeley.
TERA conducts programs similar to those by the National Toxicology Program, offering chemical-specific assessments, occupational exposure evaluations, and development of screening values modeled on approaches from the European Food Safety Authority and the Canadian Environmental Protection Act. Activities include peer review workshops held with participants from U.S. Environmental Protection Agency regional offices, training seminars attended by representatives of the World Bank and the United Nations Environment Programme, and collaboration with consortia such as the Chemical Industry Institute of Toxicology. TERA also contributes to databases and tools used alongside resources like the Integrated Risk Information System and the Hazardous Substances Data Bank.
Methodologically, TERA applies dose-response assessment, uncertainty factor frameworks, and physiologically based pharmacokinetic modelling drawing on approaches from the National Research Council reports and the European Chemicals Agency guidance. Publications include technical reports, white papers, and peer-reviewed articles prepared in formats comparable to reports from the International Agency for Research on Cancer monographs and the Agency for Toxic Substances and Disease Registry toxicological profiles. Its work has been cited in literature alongside studies from Environmental Science & Technology, Toxicological Sciences, and journals affiliated with the Society of Environmental Toxicology and Chemistry.
TERA has engaged in policy discussions with regulatory agencies like the U.S. Environmental Protection Agency, the European Commission, and the Food and Agriculture Organization of the United Nations, and has participated in advisory panels convened by the National Institutes of Health and the World Health Organization. Stakeholder engagement has included workshops with representatives of the American Petroleum Institute, labor organizations such as the AFL–CIO, and public interest groups aligned with the Natural Resources Defense Council. TERA’s assessments have informed guidance documents, regulatory risk values, and remediation strategies used by state agencies including the California Environmental Protection Agency and the New Jersey Department of Environmental Protection.
TERA has faced scrutiny typical of organizations operating at the interface of science and policy, with critics citing potential conflicts of interest when funded by industry clients similar to controversies involving the American Chemistry Council and analyses linked to the Tobacco Industry Research Committee. Debates have paralleled discussions involving transparency and reproducibility addressed by the National Academies and contested reviews reminiscent of disputes seen in assessments by the Intergovernmental Panel on Climate Change and regulatory decisions challenged in courts such as the United States Court of Appeals for the District of Columbia Circuit. Responses have emphasized peer review and disclosure practices in line with guidelines from the International Committee of Medical Journal Editors.
Category:Non-profit organizations based in the United States